Skip to main content
Clinical Trials/NCT07018167
NCT07018167Active, not recruitingNot Applicable

Impact of Door-to-Needle Time on Stroke Outcomes at Gonesse Hospital

Centre Hospitalier de Gonesse1 site in 1 country61 target enrollmentStarted: May 1, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
61
Locations
1
Primary Endpoint
Time (in minutes) from hospital arrival to thrombolysis (Door-to-Needle Time).

Study Overview

Brief Summary

This study looks at how quickly stroke patients receive treatment after arriving at Gonesse Hospital and whether this affects their recovery. Researchers will measure the time between a patient's arrival and the start of clot-busting treatment (called Door-to-Needle Time), as well as the time from symptom onset to hospital arrival (Home-Time). The goal is to see if treatment delays impact recovery, and to find ways to improve stroke care in the hospital.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients aged 18 years or older
  • •Confirmed diagnosis of acute ischemic stroke on imaging
  • •Initial acute stroke care provided at Gonesse Hospital during the study period (3 months)
  • •Intravenous thrombolysis (r-tPA) initiated at the hospital
  • •Availability of clinical and timing data to calculate Door-to-Needle Time (DNT)

Exclusion Criteria

  • •Patients with hemorrhagic stroke or subarachnoid hemorrhage (SAH)
  • •Thrombolysis initiated before hospital arrival
  • •Missing, incomplete, or unusable timing data for DNT calculation

Outcomes

Primary Outcomes

Time (in minutes) from hospital arrival to thrombolysis (Door-to-Needle Time).

Time Frame: 3 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Centre Hospitalier de Gonesse
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Impact of Door-to-Needle Time on Stroke... | Clinical Trial